Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 12(7): e0181942, 2017.
Article in English | MEDLINE | ID: mdl-28742838

ABSTRACT

Tuberculosis (TB) remains a major global health challenge and the development of a better vaccine takes center stage in fighting the disease. For this purpose, animal models that are capable of replicating the course of the disease and are suitable for the early-stage screening of vaccine candidates are needed. A Mycobacterium marinum infection in adult zebrafish resembles human TB. Here, we present a pre-clinical screen for a DNA-based tuberculosis vaccine in the adult zebrafish using an M. marinum infection model. We tested 15 antigens representing different types of mycobacterial proteins, including the Resuscitation Promoting factors (Rpf), PE/PPE protein family members, other membrane proteins and metabolic enzymes. The antigens were expressed as GFP fusion proteins, facilitating the validation of their expression in vivo. The efficiency of the antigens was tested against a low-dose intraperitoneal M. marinum infection (≈ 40 colony forming units), which mimics a primary M. tuberculosis infection. While none of the antigens was able to completely prevent a mycobacterial infection, four of them, namely RpfE, PE5_1, PE31 and cdh, led to significantly reduced bacterial burdens at four weeks post infection. Immunization with RpfE also improved the survival of the fish against a high-dose intraperitoneal injection with M. marinum (≈ 10.000 colony forming units), resembling the disseminated form of the disease. This study shows that the M. marinum infection model in adult zebrafish is suitable for the pre-clinical screening of tuberculosis vaccines and presents RpfE as a potential antigen candidate for further studies.


Subject(s)
Antigens, Bacterial/immunology , Fish Diseases/prevention & control , Mycobacterium Infections, Nontuberculous/prevention & control , Mycobacterium marinum/immunology , Tuberculosis Vaccines/therapeutic use , Animals , Antigens, Bacterial/therapeutic use , Disease Models, Animal , Fish Diseases/immunology , Fish Diseases/microbiology , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/veterinary , Zebrafish/immunology , Zebrafish/microbiology
2.
Adv Immunol ; 134: 137-233, 2017.
Article in English | MEDLINE | ID: mdl-28413021

ABSTRACT

Immune regulation by cytokines is crucial in maintaining immune homeostasis, promoting responses to infection, resolving inflammation, and promoting immunological memory. Additionally, cytokine responses drive pathology in immune-mediated disease. A crucial cytokine in the regulation of all aspects of an immune response is transforming growth factor beta (TGFß). Although best known as a crucial regulator of T cell responses, TGFß plays a vital role in regulating responses mediated by virtually every innate and adaptive immune cell, including dendritic cells, B cells, NK cells, innate lymphoid cells, and granulocytes. Here, we review our current knowledge of how TGFß regulates the immune system, highlighting the multifunctional nature of TGFß and how its function can change depending on location and context of action.


Subject(s)
Adaptive Immunity/immunology , Immunity, Innate/immunology , Transforming Growth Factor beta/immunology , Animals , Humans
3.
Vaccine ; 31(45): 5202-9, 2013 Oct 25.
Article in English | MEDLINE | ID: mdl-24055305

ABSTRACT

Tuberculosis remains a major global health challenge despite extensive vaccination schemes with the current live vaccine, Bacillus Calmette-Guérin. Tuberculosis vaccine research has been hampered by a scarcity of animal models which replicate human disease and are suitable for large-scale studies. We have shown recently that Mycobacterium marinum, a close relative of Mycobacterium tuberculosis, causes an infection resembling human tuberculosis in adult zebrafish (Danio rerio). In the present study we use this model to show that BCG vaccination as well as DNA vaccination with selected mycobacterial antigens (Ag85B, CFP-10 and ESAT-6) protects adult zebrafish from mycobacterial infection. Using a low-dose (∼20-30 bacteria) intraperitoneal M. marinum infection, both the number of granulomas and the amount of infected organs were reduced in the DNA vaccinated fish. Likewise, when infecting with a lethal infection dose (∼20,000-27,000 bacteria), vaccination significantly reduced both mortality and bacterial counts in a manner dependent on the adaptive immune response. Protective effects of vaccination were associated with enhanced expression of interferon gamma. Our results indicate that the zebrafish is a promising new model for preclinical tuberculosis vaccine research.


Subject(s)
Disease Models, Animal , Drug Discovery/methods , Mycobacterium marinum/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis Vaccines/immunology , Tuberculosis Vaccines/isolation & purification , Tuberculosis/prevention & control , Animals , Humans , Interferon-gamma/metabolism , Mycobacterium marinum/pathogenicity , Survival Analysis , Tuberculosis/immunology , Tuberculosis/pathology , Tuberculosis Vaccines/administration & dosage , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...